Jacobs Levy Equity Management, Inc Vericel Corp Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Vericel Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 62,938 shares of VCEL stock, worth $2.28 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
62,938Holding current value
$2.28 Million% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding VCEL
# of Institutions
290Shares Held
54.1MCall Options Held
36.7KPut Options Held
6.4K-
Black Rock Inc. New York, NY8.06MShares$292 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$127 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.88MShares$105 Million3.98% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$89.4 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$88.4 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.71B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...